162 related articles for article (PubMed ID: 29804188)
1. Neutrophils as a Potential Source of Chitinase-3-like Protein 1 in Cystic Fibrosis.
Coriati A; Massé C; Ménard A; Bouvet GF; Berthiaume Y
Inflammation; 2018 Oct; 41(5):1631-1639. PubMed ID: 29804188
[TBL] [Abstract][Full Text] [Related]
2. Association between serum YKL-40 level and dysglycemia in cystic fibrosis.
Bouvet GF; Maignan M; Arslanian E; Coriati A; Rabasa-Lhoret R; Berthiaume Y
Cytokine; 2015 Feb; 71(2):296-301. PubMed ID: 25497736
[TBL] [Abstract][Full Text] [Related]
3. YKL-40 as marker of severe lung disease in cystic fibrosis patients.
Leonardi S; Parisi GF; Capizzi A; Manti S; Cuppari C; Scuderi MG; Rotolo N; Lanzafame A; Musumeci M; Salpietro C
J Cyst Fibros; 2016 Sep; 15(5):583-6. PubMed ID: 26778616
[TBL] [Abstract][Full Text] [Related]
4. YKL-40 as a clinical biomarker in adult patients with CF: Implications of a CHI3L1 single nucleotide polymorphism in disease severity.
Coriati A; Bouvet GF; Massé C; Ducruet T; Berthiaume Y
J Cyst Fibros; 2021 Nov; 20(6):e93-e99. PubMed ID: 33277205
[TBL] [Abstract][Full Text] [Related]
5. Peripheral blood mononuclear cell response to YKL-40 and Galectin-3 in cystic fibrosis.
Bouvet GF; Bulka O; Coriati A; Sognigbé L; St-Pierre G; Massé C; Sato S; Berthiaume Y
Cytokine; 2021 Oct; 146():155635. PubMed ID: 34274729
[TBL] [Abstract][Full Text] [Related]
6. Airway, but not serum or urinary, levels of YKL-40 reflect inflammation in early cystic fibrosis lung disease.
Fantino E; Gangell CL; Hartl D; Sly PD;
BMC Pulm Med; 2014 Feb; 14():28. PubMed ID: 24576297
[TBL] [Abstract][Full Text] [Related]
7. The chitinase-like protein YKL-40 modulates cystic fibrosis lung disease.
Hector A; Kormann MS; Mack I; Latzin P; Casaulta C; Kieninger E; Zhou Z; Yildirim AÖ; Bohla A; Rieber N; Kappler M; Koller B; Eber E; Eickmeier O; Zielen S; Eickelberg O; Griese M; Mall MA; Hartl D
PLoS One; 2011; 6(9):e24399. PubMed ID: 21949714
[TBL] [Abstract][Full Text] [Related]
8. Increased Plasma YKL-40 Level and Chitotriosidase Activity in Cystic Fibrosis Patients.
Topcu DB; Tugcu G; Er B; Polat SE; Hizal M; Yalcin EE; Ersoz DD; Coplu L; Ozcelik U; Kiper N; Lay I; Oztas Y
Inflammation; 2022 Apr; 45(2):627-638. PubMed ID: 34637032
[TBL] [Abstract][Full Text] [Related]
9. The relationship between serum YKL-40 levels and arterial stiffness in patients with ankylosing spondylitis.
Kucukali Turkyilmaz A; Devrimsel G; Serdaroglu Beyazal M; Kirbas A; Cicek Y; Capkin E; Karkucak M; Gokmen F
Acta Reumatol Port; 2017; 42(2):183-190. PubMed ID: 27680106
[TBL] [Abstract][Full Text] [Related]
10. Chitinase-3-Like Protein 1 (YKL-40) Reflects the Severity of Symptoms in Atopic Dermatitis.
Salomon J; Matusiak Ł; Nowicka-Suszko D; Szepietowski JC
J Immunol Res; 2017; 2017():5746031. PubMed ID: 28660216
[TBL] [Abstract][Full Text] [Related]
11. Identification of neutrophil activation markers as novel surrogate markers of CF lung disease.
Rath T; Zwaschka L; Hage L; Kügler M; Menendez K; Naehrlich L; Schulz R; Roderfeld M; Roeb E
PLoS One; 2014; 9(12):e115847. PubMed ID: 25545245
[TBL] [Abstract][Full Text] [Related]
12. Chitinase-3-Like Protein 1 (YKL-40) Is a New Biomarker of Inflammation in Psoriasis.
Salomon J; Matusiak Ł; Nowicka-Suszko D; Szepietowski JC
Mediators Inflamm; 2017; 2017():9538451. PubMed ID: 28932021
[TBL] [Abstract][Full Text] [Related]
13. Serum YKL-40 as predictor of outcome in hypersensitivity pneumonitis.
Long X; He X; Ohshimo S; Griese M; Sarria R; Guzman J; Costabel U; Bonella F
Eur Respir J; 2017 Feb; 49(2):. PubMed ID: 27836954
[TBL] [Abstract][Full Text] [Related]
14. Circulating and airway neutrophils in cystic fibrosis display different TLR expression and responsiveness to interleukin-10.
Petit-Bertron AF; Tabary O; Corvol H; Jacquot J; Clément A; Cavaillon JM; Adib-Conquy M
Cytokine; 2008 Jan; 41(1):54-60. PubMed ID: 18054497
[TBL] [Abstract][Full Text] [Related]
15. A longitudinal assessment of circulating YKL-40 levels in preschool children with wheeze.
James A; Stenberg Hammar K; Reinius L; Konradsen JR; Dahlén SE; Söderhäll C; Hedlin G
Pediatr Allergy Immunol; 2017 Feb; 28(1):79-85. PubMed ID: 27732738
[TBL] [Abstract][Full Text] [Related]
16. Elevated serum YKL-40 levels in patients with Kawasaki disease.
Kim KY; Ahn Y; Kim DY; Kim HS; Kim DS
Biomarkers; 2017; 22(3-4):326-330. PubMed ID: 27881022
[TBL] [Abstract][Full Text] [Related]
17. Chitinase-3-like Protein 1 (YKL-40) Is Expressed in Lesional Skin in Hidradenitis Suppurativa.
Salomon J; Piotrowska A; Matusiak Ł; Dzięgiel P; Szepietowski JC
In Vivo; 2019; 33(1):141-143. PubMed ID: 30587614
[TBL] [Abstract][Full Text] [Related]
18. Serum YKL-40 as a potential biomarker of inflammation in psoriasis.
Baran A; Myśliwiec H; Szterling-Jaworowska M; Kiluk P; Świderska M; Flisiak I
J Dermatolog Treat; 2018 Feb; 29(1):19-23. PubMed ID: 28498006
[TBL] [Abstract][Full Text] [Related]
19. Elevated circulating levels of the serum acute-phase protein YKL-40 (chitinase 3-like protein 1) are a marker of obesity and insulin resistance in prepubertal children.
Kyrgios I; Galli-Tsinopoulou A; Stylianou C; Papakonstantinou E; Arvanitidou M; Haidich AB
Metabolism; 2012 Apr; 61(4):562-8. PubMed ID: 22036069
[TBL] [Abstract][Full Text] [Related]
20. Serum YKL-40 as a marker of liver fibrosis in patients with non-alcoholic fatty liver disease.
Kumagai E; Mano Y; Yoshio S; Shoji H; Sugiyama M; Korenaga M; Ishida T; Arai T; Itokawa N; Atsukawa M; Hyogo H; Chayama K; Ohashi T; Ito K; Yoneda M; Kawaguchi T; Torimura T; Nozaki Y; Watanabe S; Mizokami M; Kanto T
Sci Rep; 2016 Oct; 6():35282. PubMed ID: 27739482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
